Technology|Medical 3-D Printing| February 14, 2019

Software can process medical imaging data and export output files for surgical treatment and evaluation

Synopsys Releases Simpleware ScanIP Medical Software for 3-D Printing

February 14, 2019 — Smart technology company Synopsys recently announced the release of the Synopsys Simpleware ScanIP Medical edition for3-D printingandvisualization. This new version of Simpleware ScanIP comes with U.S. Food and Drug Administration (FDA) 510(k) clearance, and CE and ISO 13485:2016 certification as a medical device.

According to the company, Simpleware ScanIP Medical is the ideal choice for those working with 3-D imaging to create medical devices for pre-clinical workflows such as implant design and patient-specific planning. Developed and maintained to international standards for medical device software, Simpleware ScanIP Medical comes with all the features of ScanIP but is specifically intended for medical usage. Users can process medical imaging data and export output files to simulate/evaluate pre-surgical treatment options.

Workflow highlights of the software include:

  • Import and anonymize patient DICOM tags from the picture archiving and communication system (PACS) server. The software is DICOM 3.0 compliant;

  • Combine computer-aided detection (CAD) and imaging data for patient-specific analysis;

  • Rapidly segment and process medical images with easy-to-use interface;

  • Obtain reliable data for complex anatomical analysis using measurement and statistics tools; and

  • Export geometrically accurate models for pre-surgical planning

Key benefits associated with Simpleware ScanIP Medical include:

  • Intuitive, fully supported user interface tested by medical professionals;

  • Compliant with privacy standards for handling patient data;

  • Achieve ideal surgical outcomes based on insights from imaging data;

  • Improve understanding of patient anatomy when designing unique medical devices;

  • Streamline software resources with complete medical image processing platform for the R&D workstation, radiology department or other clinical work environments; and

  • Build confidence in surgical decision-making by simplifying time-consuming workflows.

For more information:www.synopsys.com

Related Content

Adaptiiv is pioneering new approaches to bring personalization at scale to patients all over the world and is collaborating with HP and Varian to advance these efforts and meet evolving customer needs
News|Medical 3-D Printing

May 11, 2022 — Adaptiiv Medical Technologies is collaborating with HP Inc. and Varian, a Siemens Healthineers company ...

TimeMay 11, 2022
arrow
Videos|Radiation Oncology

Douglas E. Holt, M.D., a radiation oncologist at Eastern Idaho Regional Medical Center, explains the use of 3-D virtual ...

TimeFebruary 02, 2022
arrow
Videos|Computed Tomography (CT)

Cynthia McCollough, Ph.D., director of Mayo Clinic's CT Clinical Innovation Center, explains how photon-counting ...

TimeJanuary 27, 2022
arrow
Cydar EV Maps有助于血管内手术的规划、实时指导和术后回顾。
News|Mobile C-Arms

2022年1月18日消息——飞利浦医疗保健宣布,医生现在将可以使用先进的新的3D图像指导……

TimeJanuary 18, 2022
arrow
Canon's Vitrea PACS enterprise imaging system was one of several systems demonstrated at HIMSS 2021 that had easily modified hanging protocols. This included ease of use to customize what each radiologists prefers, including slice thickness. #HIMSS #HIMSS21
Feature|Enterprise Imaging

Taking advantage of new technology advances, several radiology PACS, enterprise imaging and cardiovascular information ...

TimeNovember 04, 2021
arrow
The Siemens Naeotom Alpha is the first commercialized photon-counting CT scanner. It gained FDA clearance Sept. 30, 2021. The image shows the system undergoing phantom testing with the outer covers off, showing the motion of the X-ray source and detector ring. Image by Deutscher Zukunftpreis/Ansgar Pudenz.
Feature|Computed Tomography (CT)| By Dave Fornell, ITN Editor

The U.S. Food and Drug Administration (FDA) cleared the world's first photon-counting computed tomography (CT) scanner ...

TimeNovember 04, 2021
arrow
Cardiac CTA derived left atrium emptying fraction (LAEF) improves predictive performance of established clinical risk scores and may be used to assess TAVR patient risk during pre-procedure workup and post-procedural surveillance. These images show LAVmax (A and B), LAVmin (C and D), and LAEF using cardiac CTA. LAEF was calculated as (LAVmax-LAVmin)/LAVmax x 100. Given LAVmax of 109 mL and LAVmin of 80 mL, the LAEF was calculated to be 27%. Image courtesy of AJR.
News|Computed Tomography (CT)

October 14, 2021 — Cardiac computed tomography angiography (CTA) derived left atrium emptying fraction (LAEF) improves ...

TimeOctober 14, 2021
arrow
Videos|Enterprise Imaging

ITN Editor Dave Fornell collected numerous examples of how PACS and enterprise imaging vendors are improving the speed ...

TimeSeptember 03, 2021
arrow
Videos|Coronavirus (COVID-19)

Several radiology IT vendors at 2021 Healthcare Information Management Systems Society (HIMSS) conference demonstrated ...

TimeAugust 31, 2021
arrow
SyntheticMR and Siemens Healthineers signed a cooperation agreement in 2016, since 2018, SyMRI NEURO has been available for purchase on the Siemens Healthineers Digital Marketplace. The product can be seamlessly integrated in the clinical workflow.
News|Advanced Visualization

August 17, 2021 — SyntheticMR and Siemens Healthineers signed a cooperation agreement in 2016, since 2018, SyMRI NEURO ...

TimeAugust 17, 2021
arrow
Subscribe Now